Cargando…
Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines
The prognosis of patients with pancreatic cancer continues to remain dismal, even though numerous trials have been conducted to establish more effective therapies in Japan and throughout the world. Recent advances in treatment have been characterized by the use of novel combinations of conventional...
Autores principales: | Okusaka, Takuji, Furuse, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080663/ https://www.ncbi.nlm.nih.gov/pubmed/31997007 http://dx.doi.org/10.1007/s00535-020-01666-y |
Ejemplares similares
-
Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis
por: Okusaka, Takuji, et al.
Publicado: (2020) -
Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan
por: Furuse, Junji
Publicado: (2019) -
Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis
por: Furuse, Junji, et al.
Publicado: (2017) -
Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011) -
Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer
por: Okusaka, Takuji, et al.
Publicado: (2014)